Lead

Hims & Hers, the telehealth and wellness firm, announced a $300 million convertible debt offering on Thursday, pricing the notes at $10.10 each. The transaction, aimed at raising capital for growth initiatives, came at a time when the market for convertible debt was weak, leading to a modest decline in the company’s share price.

Background

Hims & Hers, founded in 2017, has built a portfolio of health and wellness brands that include Hims, Hers, and other specialty lines. The company has pursued aggressive expansion through acquisitions and product development, which has driven its need for additional capital. Convertible debt offers a hybrid financing tool that combines the benefits of debt with the potential upside of equity conversion, often used by growth‑stage companies to avoid immediate dilution.

What Happened

The company filed a registration statement with the Securities and Exchange Commission on March 29, 2024, to issue 30 million senior unsecured convertible notes with a face value of $10.10 each, totaling $300 million. The notes have a 10.5% coupon rate and mature in 2029. They are convertible into common stock at a conversion price of $10.10 per share, with a 20% discount to the closing price on the first day of the offering. The offering was priced at $10.10 per note, reflecting the current market conditions for convertible debt.

On the day of the announcement, Hims & Hers’ shares fell 0.4% to $20.70, a decline attributed to the broader softness in the convertible debt market. The company’s stock had been trading near a $20.70 level for the past week, with a 52‑week range of $17.50 to $26.10. The offering was priced at a discount to the company’s current share price, which was trading at $22.30 at the time of the announcement.

Market & Industry Implications

The deal highlights the challenges faced by companies in raising convertible debt during periods of market uncertainty. Analysts note that the pricing of the notes at $10.10 per share, below the current trading price, indicates a cautious approach to investor demand. The convertible debt market has been under pressure, with other issuers reporting weaker demand and lower pricing in recent months. This environment may affect future financing strategies for companies in the health and wellness sector, which rely on debt instruments to fund acquisitions and product development.

For investors, the offering provides a fixed‑income instrument with a 10.5% coupon and the potential for equity upside if the company’s stock price rises above the conversion price. However, the current market conditions suggest that the conversion feature may be less attractive, potentially limiting the upside for investors.

What to Watch

  • Hims & Hers will file the final prospectus with the SEC, which will detail the terms of the offering and any covenants associated with the notes.
  • The company’s next earnings release, scheduled for Q2 2024, will provide insight into how the raised capital is being deployed and its impact on revenue and profitability.
  • Market sentiment toward convertible debt will continue to influence the pricing and demand for similar offerings in the health and wellness sector.